The Blavatnik Fund for Innovation at Yale bridges the gap between innovative, early-stage life science research and successful development of high-impact biomedical products. Our integrated approach combines essential funding with development and business expertise, leading to commercial partnerships that bring forth new biomedical discoveries that create value and benefit society.

Featured News

May 30, 2017
Yale Sterling Chemistry Professor Alanna Schepartz had a major breakthrough when she discovered cell-penetrating miniature proteins. She’s now won a $300,000 Blavatnik...

Featured Videos

Upcoming Events

No events to display.